NCT00167544View on ClinicalTrials.gov

Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

November 30, 2012

Conditions
Bronchopulmonary DysplasiaEncephalomalaciaPremature Birth
Interventions
DRUG

Hydrocortisone

Hydrocortisone 3 mg/kg/d divided q 12h IV/PO tapered over 7 days

DRUG

Placebo

Saline

Trial Locations (1)

432025

Nationwide Children's Hospital, Columbus

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Nationwide Children's Hospital

OTHER

NCT00167544 - Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants | Biotech Hunter | Biotech Hunter